Related Experiment Video
Updated: May 16, 2025
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
The UK Infected Blood Inquiry: A Personal Reflection
1University College London, London, UK.
Insights
The UK Infected Blood Inquiry found thousands died from contaminated blood products, leading to a potential £14 billion compensation package. This reflection highlights the historical context of haemophilia treatment and advocates for no-fault compensation schemes.
Area of Science:
- Medical history
- Public health policy
- Infectious diseases
Background:
- The UK Infected Blood Inquiry (IBI) investigated deaths from transfusion-transmitted infections like hepatitis B, C, and HIV, and vCJD.
- The inquiry, spanning 2018-2024, reported significant findings on May 20, 2024, highlighting systemic failures.
- A personal reflection focuses on individuals with haemophilia infected through blood products, examining the long history of understanding these infections.
Purpose of the Study:
- To reflect on the historical context of treating haemophilia with blood products.
- To analyze the findings of the UK Infected Blood Inquiry regarding transfusion-transmitted infections.
- To advocate for improved patient compensation and the protection of evidence-based medicine.
Main Methods:
- Review of the UK Infected Blood Inquiry's findings and report.
- Historical analysis of medical practices in treating haemophilia over 40 years.
- Personal reflection on the experiences of physicians and patients.
Main Results:
- The IBI concluded at least 3000 deaths resulted from "recklessness and obstinacy of officialdom."
- Estimated compensation for victims ranges from £12 billion to £14 billion.
- Physicians' efforts to advance patient care with blood products were criticized despite unforeseen side effects.
Conclusions:
- The inquiry's findings underscore the tragic consequences of infected blood transfusions.
- There is a strong recommendation for establishing 'no-fault compensation' schemes.
- Protecting evidence-based medicine is crucial, especially with emerging irreversible therapies.
Abstract:
The UK Infected Blood Inquiry (IBI) considered the transfusion transmitted infections hepatitis B and C, HIV, and vCJD. The inquiry lasted 6 years during 2018 to 2024 and reported to the UK parliament on 20 May, 2024. It concluded that at least 3000 people died because of the recklessness and obstinacy of officialdom and it has been reported that victims may be compensated an estimated £12 bn-£14 bn ($16 bn-$18 bn). This personal reflection considers people with the bleeding disorder haemophilia, who were infected with blood products. The longevity of both the understanding of the infections, as well as the long natural history of the infections themselves, is set in the context of the medicine practiced by physicians with whom the author was taught and practiced over a period of 40 years. These physicians used blood products to advance the care and life expectancy of patients whilst the ill understood and unforeseen side effects of treatment were slowly elucidated: their contributions were severely criticised but their evidence could not be presented through ill health or death. It is recommended that 'no-fault compensation' schemes should be provided, especially in the era of new and sometimes irreversible therapies, and evidence-based medicine is protected.
Related Concept Videos
01:18Steps in Outbreak Investigation
02:45Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:15Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
01:20Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:08Obedience